Lv11
80 积分 2022-04-20 加入
chronic kidney disease
3天前
已完结
Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells
4个月前
已完结
Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells
4个月前
已关闭
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
4个月前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
4个月前
已完结
New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy
5个月前
已完结